Publication list
2023
Kacsir, I.,
Sipos, A.,
Kiss, T.,
Major, E.,
Bajusz, N.,
Tóth, E.,
Buglyó, P.,
Somsák, L.,
Kardos, G.,
Bai, P.,
Bokor, É.:
Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria.
Front. Chem. 11 1-18, 2023.
Journal metrics:
Q1 Chemistry (miscellaneous) (2022)
Szász, I.,
Kiss, T.,
Mokánszki, A.,
Koroknai, V.,
Deák, J.,
Patel, V.,
Jámbor, K.,
Ádány, R.,
Balázs, M.:
Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
Mol. Cell. Probes. 67 1-8, 2023.
Journal metrics:
Q3 Cell Biology (2022)
Q3 Molecular Biology (2022)
2022
Jámbor, K.,
Koroknai, V.,
Kiss, T.,
Szász, I.,
Pikó, P.,
Balázs, M.:
Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.
Pathol. Oncol. Res. 28 1-12, 2022.
Journal metrics:
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology
Q2 Pathology and Forensic Medicine
2021
Szász, I.,
Koroknai, V.,
Patel, V.,
Hajdú, T.,
Kiss, T.,
Ádány, R.,
Balázs, M.:
Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines.
Biomedicines. 9 (2), 1-18, 2021.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
Patel, V.,
Szász, I.,
Koroknai, V.,
Kiss, T.,
Balázs, M.:
Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.
Cancers (Basel). 13 (23), 1-22, 2021.
Journal metrics:
Q2 Cancer Research
Q1 Oncology
Kiss, T.,
Jámbor, K.,
Koroknai, V.,
Szász, I.,
Bárdos, H.,
Mokánszki, A.,
Ádány, R.,
Balázs, M.:
Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Pathol. Oncol. Res. 27 1-10, 2021.
Journal metrics:
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology
Q2 Pathology and Forensic Medicine
2019
Szász, I.,
Koroknai, V.,
Kiss, T.,
Vízkeleti, L.,
Ádány, R.,
Balázs, M.:
Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells.
Melanoma Res. 29 (4), 390-400, 2019.
Journal metrics:
Q3 Cancer Research
Q1 Dermatology
Q2 Oncology
2017
Vízkeleti, L.,
Kiss, T.,
Koroknai, V.,
Ecsedi, S.,
Papp, O.,
Szász, I.,
Ádány, R.,
Balázs, M.:
Altered integrin expression patterns revealed by microarray in human cutaneous melanoma.
Melanoma Res. 27 (3), 180-188, 2017.
Journal metrics:
Q2 Cancer Research
Q1 Dermatology
Q2 Oncology
2016
Koroknai, V.,
Ecsedi, S.,
Vízkeleti, L.,
Kiss, T.,
Szász, I.,
Lukács, A.,
Papp, O.,
Ádány, R.,
Balázs, M.:
Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
Melanoma Res. 2 100-107, 2016.
Journal metrics:
Q2 Cancer Research
Q1 Dermatology
Q2 Oncology
2015
Kiss, T.,
Ecsedi, S.,
Vízkeleti, L.,
Koroknai, V.,
Emri, G.,
Kovács, N.,
Ádány, R.,
Balázs, M.:
The role of osteopontin expression in melanoma progression.
Tumor Biol. 36 (10), 7841-7847, 2015.
Journal metrics:
Q2 Cancer Research
Q1 Medicine (miscellaneous)
2014
Ecsedi, S.,
Hernandez, -.,
Lima, S.,
Vízkeleti, L.,
Tóth, R.,
Lázár, V.,
Koroknai, V.,
Kiss, T.,
Emri, G.,
Herceg, Z.,
Ádány, R.,
Balázs, M.:
DNA methylation characteristics of primary melanomas with distinct biological behaviour.
PloS One. 9 (5), e96612, 2014.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2012
Vízkeleti, L.,
Ecsedi, S.,
Rákosy, Z.,
Orosz, A.,
Lázár, V.,
Emri, G.,
Koroknai, V.,
Kiss, T.,
Ádány, R.,
Balázs, M.:
The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
Tumor Biol. 33 (6), 2189-2199, 2012.
Journal metrics:
Q3 Cancer Research
Q1 Medicine (miscellaneous)
updated: 2023-05-28, 02:18
